79110-05-7

Basic information

• Product Name: 1-(2-Fluoro-5-nitrophenyl)ethan-1-one
• Synonyms: 1-(2-Fluoro-5-nitrophenyl)ethan-1-one;2'-Fluoro-5'-nitroacetophenone 96%;1-(2-Fluoro-5-nitrophenyl)ethanone;1-(2-Fluoro-5-nitrophenyl)ethan-1-one, 3-Acetyl-4-fluoronitrobenzene;Ethanone,1-(2-fluoro-5-nitrophenyl)-
• CAS NO: 79110-05-7
• Molecular Formula: C₈H₆FNO₃
• Molecular Weight: 183.1365432
• EINECS: 1533716-785-6
• Product Categories: Fluorine series
• Mol File: 79110-05-7.mol
• Article Data: 20

Chemical Properties

• Melting Point: 53-54 °C
• Boiling Point: 241 °C at 760 mmHg
• Flash Point: 99.6 °C
• Appearance: /
• Density: 1.336 g/cm³
• Vapor Pressure: 0.0367mmHg at 25°C
• Refractive Index: 1.537
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-(2-Fluoro-5-nitrophenyl)ethan-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-Fluoro-5-nitrophenyl)ethan-1-one(79110-05-7)
• EPA Substance Registry System: 1-(2-Fluoro-5-nitrophenyl)ethan-1-one(79110-05-7)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 79110-05-7(Hazardous Substances Data)

Usage

Uses

2''-Fluoro-5''-nitroacetophenone

InChI:InChI=1/C8H6FNO3/c1-5(11)7-4-6(10(12)13)2-3-8(7)9/h2-4H,1H3

Upstream product

• 445-27-2 2'-Fluoroacetophenone 
• 709-46-6 2-fluoro-5-nitrobenzoyl chloride 
• 75-16-1 methylmagnesium bromide 
• 701-45-1 2-bromo-1-fluoro-4-nitrobenzene 
• 97674-02-7 tributyl(1-ethoxyvinyl)stannane 

Downstream Products

• 125764-46-7 5-nitro-2-fluoro-(2,4,5-trimethyl-1,3-dioxolan-2-yl)benzene 
• 1006059-93-3 2-(2,2-dichloro-1-methylvinyl)-1-fluoro-4-nitrobenzene 
• 477312-51-9 1-(2-fluoro-5-morpholin-4-yl-phenyl)-ethanone 

Relevant articles and documents

NOVEL CRYSTALLINE FORMS OF A BACE INHIBITOR, COMPOSITIONS, AND THEIR USE

The present invention provides a novel synthesis of verubecestat, and two novel crystalline forms of verubecestat, as well as pharmaceutically acceptable compositions thereof, each of which may be useful in treating, preventing, ameliorating, and/or delay

NOVEL CRYSTALLINE FORMS OF A BACE INHIBITOR, COMPOSITIONS, AND THEIR USE

The present invention provides four crystalline forms of verubecestat, as well as pharmaceutically acceptable compositions thereof, each of which may be useful in treating, preventing, ameliorating, and/or delaying the onset of an Aβ pathology and/or a sy

C2-CARBOCYCLIC IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

In its many embodiments, the present invention provides certain C2-carbocyclic iminothiazine dioxide compounds, including compounds Formula (I); or a tautomers thereof, and pharmaceutically acceptable salts of said compounds and said tautomers, wherein R1, R2, ring A, RA, m, ring B, RB, n, ring C, RC and p are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed.